Its GLP-1 weight-loss program is a newer option, designed for people with a BMI of 30+ (or 27+ with certain health conditions) who may benefit from medications like semaglutide
The patches rely on herbal ingredients with weak or no clinical evidence for weight loss, especially through a patch
Animal studies have shown thyroid C-cell tumours with some GLP-1 receptor agonists, though the relevance to humans is uncertain
Peptides.org makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available
It is also, per recent mechanistic work, responsible for PCSK9 degradation, which is the likely pathway behind the LDL cholesterol reductions seen in TRIUMPH-4
The D-glucose moiety is depicted in yellow, with heteroatoms coloured in red